Researchers have discovered a potential new biomarker for Parkinson’s disease using machine learning technology. This could lead to earlier diagnosis and treatment of the disease, which currently affects 10 million people worldwide. The biomarker is a panel of eight blood-based markers that can be easily tested in a lab setting.